NanoSpot.ai has developed an innovative agglutination-based platform for measuring antibody levels in fingerstick blood samples. By leveraging the NanoSpot.ai mobile application and artificial intelligence, NanoSpot.ai is able to deliver quantitative, rapid (<3 minute sample-to-answer), low-cost, and accurate antibody testing that is optimized for the point of care environment.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
YesProducts to be exported:
NanoSpot.ai SARS-CoV-2 Total Antibody TestBusiness Needs:
Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements